P. Chavanet
Impact in
- Infectious Diseases top 1%
- Antifungal resistance and susceptibility
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 20
- Antifungal resistance and susceptibility 17
- Antimicrobial Resistance in Staphylococcus 15
- Epidemiology 68
- Pneumonia and Respiratory Infections 28
- Co-authors
- H. Portier (66 shared papers)Lionel Piroth (75 shared papers)Michel Duong (41 shared papers)Michèle Grappin (26 shared papers)Marielle Buisson (20 shared papers)Pierre‐Emmanuel Charles (17 shared papers)Denis Caillot (17 shared papers)Serge Aho (16 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (15 papers)Antimicrobial Agents and Chemotherapy (10 papers)HIV Clinical Trials (6 papers)Clinical Microbiology and Infection (5 papers)BMC Infectious Diseases (4 papers)
- Partner nations
- FranceUnited StatesMali
In The Last Decade
P. Chavanet
178 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 127
- Infectious Diseases 1.4k
- Applied Microbiology and Biotechnology 120
- Molecular Medicine 270
- Virology 236
- Emergency Medicine 407
Countries citing papers authored by P. Chavanet
This map shows the geographic impact of P. Chavanet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Chavanet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Chavanet more than expected).
Fields of papers citing papers by P. Chavanet
This network shows the impact of papers produced by P. Chavanet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Chavanet. The network helps show where P. Chavanet may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Chavanet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 186 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 159 | |
| 2 | 2005 | 132 | |
| 3 | 2001 | 98 | |
| 4 | 2003 | 96 | |
| 5 | 2002 | 89 | |
| 6 | 2001 | 86 | |
| 7 | 2001 | 75 | |
| 8 | 2005 | 73 | |
| 9 | 1992 | 69 | |
| 10 | 2004 | 61 | |
| 11 | 1993 | 61 | |
| 12 | 1990 | 60 | |
| 13 | 1989 | 59 | |
| 14 | 2008 | 59 | |
| 15 | 1992 | 56 | |
| 16 | 1992 | 56 | |
| 17 | 1994 | 54 | |
| 18 | 1994 | 52 | |
| 19 | 2014 | 51 | |
| 20 | Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment. | 2007 | 50 |
About P. Chavanet
P. Chavanet is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Molecular Medicine and Emergency Medicine, having authored 186 papers that have together received 3.6k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (28 papers), Antibiotics Pharmacokinetics and Efficacy (25 papers), HIV/AIDS drug development and treatment (20 papers), Antibiotic Resistance in Bacteria (19 papers), Antifungal resistance and susceptibility (17 papers), Antimicrobial Resistance in Staphylococcus (15 papers), HIV-related health complications and treatments (14 papers) and HIV Research and Treatment (11 papers). The work is most often cited by research in Infectious Diseases (1.4k citations), Applied Microbiology and Biotechnology (120 citations), Molecular Medicine (270 citations), Virology (236 citations) and Emergency Medicine (407 citations). P. Chavanet has collaborated with scholars based in France, United States and Mali. Frequent co-authors include H. Portier, Lionel Piroth, Michel Duong, Michèle Grappin, Marielle Buisson, Pierre‐Emmanuel Charles, Denis Caillot, Serge Aho, Frédéric Dalle and Delphine Croisier. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, HIV Clinical Trials, Clinical Microbiology and Infection and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.